Aly-Khan Lalani, MD Dana Farber Cancer Institute, discusses Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings at Kidney Cancer Association 2017 in Miami.
Advertisement
Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings
By Editor